Ensysce Biosciences Inc (ENSC)

May 02, 2025

Ensysce Biosciences (ENSC) to Release Earnings on Friday - Defense World

May 02, 2025

Apr 27, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 27, 2025

Apr 25, 2025

Ensysce Biosciences to Present at the H.C. Wainwright 25th Annual Global Investment Conference - ACCESS Newswire

Apr 25, 2025

Apr 25, 2025

Ensysce Biosciences Inc (ENSC) Clearly Signals Buy-Into the Stock: Don’t ignore the signals - Sete News

Apr 25, 2025

Apr 24, 2025

Ensysce Biosciences Secures $2.2M Funding Boost: Key Details on TAAP/MPAR Program Advancement - Stock Titan

Apr 24, 2025

Apr 24, 2025

Ensysce Biosciences Stock Price, Quotes and Forecasts | NASDAQ:ENSC - Benzinga

Apr 24, 2025

Apr 24, 2025

Ensysce Biosciences announces exercise of warrants for $2.2M gross proceeds - MSN

Apr 24, 2025

Apr 24, 2025

For Array Technologies Inc [ARRY], Analyst sees a rise to $7. What next? - dbtnews.com

Apr 24, 2025

Apr 24, 2025

Ensysce Biosciences (ENSC) Stock Surges on Patent News - GuruFocus

Apr 24, 2025

Apr 24, 2025

Ensysce Biosciences (ENSC) Secures $2.2 Million Through Warrant Exercise - GuruFocus

Apr 24, 2025

Apr 23, 2025

Ensysce Biosciences to raise $2.2 million through warrant exercise By Investing.com - Investing.com Canada

Apr 23, 2025

Apr 23, 2025

Ensysce Biosciences secures patent for OUD treatment By Investing.com - Investing.com South Africa

Apr 23, 2025

Apr 23, 2025

Ensysce Biosciences to raise $2.2 million through warrant exercise - Investing.com Australia

Apr 23, 2025

Apr 23, 2025

Ensysce Biosciences Inc’s Shares Reel: -58.79% Quarterly Revenue Decline Amid 5.62M Market Cap - investchronicle.com

Apr 23, 2025

Apr 23, 2025

Ensysce Biosciences Stock Doubles In One Trading SessionHere's Why - Yahoo Finance

Apr 23, 2025

Apr 23, 2025

Dropbox Inc: Weathering Stock Market Storms with 7.92B Market Cap - investchronicle.com

Apr 23, 2025

Apr 23, 2025

Nuvation Bio Inc Inc. (NUVB) Price Performance: A Technical Analysis Perspective - investchronicle.com

Apr 23, 2025

Apr 23, 2025

Ensysce Biosciences Raises Fresh $2.2M Capital: H.C. Wainwright Backs Strategic Warrant Deal - Stock Titan

Apr 23, 2025

Apr 23, 2025

Sabre Corp (SABR) Stock: From Low to High in 52 Weeks - investchronicle.com

Apr 23, 2025

Apr 23, 2025

Analysts Are Recommending Ensysce Biosciences Inc (ENSC) As A Buy Candidate - Marketing Sentinel

Apr 23, 2025

Apr 23, 2025

Ensysce Biosciences Inc (NASDAQ:ENSC) stock: You might be surprised - uspostnews.com

Apr 23, 2025

Apr 23, 2025

Amentum Holdings Inc (AMTM) Shares Are Down -4.43% YTD - Marketing Sentinel

Apr 23, 2025

Apr 23, 2025

Crude Oil Falls Over 3%; Philip Morris Earnings Top Views - Benzinga

Apr 23, 2025

Apr 23, 2025

The Psychology of Altria Group Inc Inc. (MO) Price Performance: Understanding Market Sentiment - investchronicle.com

Apr 23, 2025

Apr 23, 2025

Ensysce (ENSC) Stock Sees Market Uplift Following New Patent Approval - Stocks Telegraph

Apr 23, 2025

Apr 23, 2025

The Psychology of Metsera Inc Inc. (MTSR) Price Performance: Understanding Market Sentiment - investchronicle.com

Apr 23, 2025

Apr 23, 2025

(ENSC) Technical Data - news.stocktradersdaily.com

Apr 23, 2025

Apr 23, 2025

Safety Shot Inc Inc. (SHOT) Price Performance: A Technical Analysis Perspective - investchronicle.com

Apr 23, 2025

Apr 23, 2025

Ensysce (ENSC) Advances PF614-MPAR in Overdose Protection Trial - GuruFocus

Apr 23, 2025

Apr 23, 2025

Dow Jumps Over 1,000 Points; Tesla Shares Rise After Q1 Results - Benzinga

Apr 23, 2025

Apr 23, 2025

Trump's Trade Hints Spark US Equity Gains - Finimize

Apr 23, 2025

Apr 23, 2025

Ensysce Biosciences secures patent for OUD treatment - Investing.com

Apr 23, 2025

Apr 23, 2025

Ensysce Biosciences Gets US Patent for Opioid Use Disorder Treatment; Shares Rise Pre-Bell - marketscreener.com

Apr 23, 2025

Apr 23, 2025

AtlasClear Holdings Inc (ATCH) Stock: A Year of Stock Market Dynamics - investchronicle.com

Apr 23, 2025

Apr 23, 2025

Revolutionary Opioid Treatment Patent Promises Safer Alternative to Methadone: Key Advantages Revealed - Stock Titan

Apr 23, 2025

Apr 23, 2025

An In-Depth Look At TPG Inc (TPG) - Marketing Sentinel

Apr 23, 2025

Apr 23, 2025

DVS’s Stock Market Pendulum: Swinging Between Gains and Losses - investchronicle.com

Apr 23, 2025

Apr 22, 2025

Ensysce Biosciences files to sell 652,439 shares of common stock for holders - MSN

Apr 22, 2025

Apr 21, 2025

ENSC stock touches 52-week low at $1.7 amid market challenges By Investing.com - Investing.com South Africa

Apr 21, 2025

Apr 21, 2025

ENSC stock touches 52-week low at $1.7 amid market challenges - Investing.com Australia

Apr 21, 2025

Apr 20, 2025

Comparing Ensysce Biosciences (NASDAQ:ENSC) & MacroGenics (NASDAQ:MGNX) - Defense World

Apr 20, 2025

Apr 17, 2025

Pre-market Movers: CHRO, QURE, FOTA, LLY... - RTTNews

Apr 17, 2025

Apr 16, 2025

Ensysce Biosciences (ENSC) Plans to Sell Over 650,000 Shares - GuruFocus

Apr 16, 2025

Apr 15, 2025

Ensysce Biosciences completes key trial phase for safer opioid - Investing.com

Apr 15, 2025

Apr 15, 2025

Ensysce Biosciences announces data from opioid overdose protection study - TipRanks

Apr 15, 2025

Apr 15, 2025

Ensysce Biosciences completes key trial phase for safer opioid By Investing.com - Investing.com India

Apr 15, 2025

Apr 15, 2025

12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga

Apr 15, 2025

Apr 15, 2025

Revolutionary Opioid Drug Shows Breakthrough Overdose Protection in Clinical Trial - Stock Titan

Apr 15, 2025

Apr 14, 2025

Ensysce Biosciences Stock Rises On Positive Data From Opioid Overdose Protection Study: Retail’s Thrilled - MSN

Apr 14, 2025

Apr 10, 2025

12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga

Apr 10, 2025

Apr 07, 2025

ENSC stock touches 52-week low at $2.11 amid market challenges - Investing.com

Apr 07, 2025